Apolipoprotein CIII Reduction Via Colchicine

NCT02083510 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Hypertriglyceridemia
Gout
Pericarditis

Interventions

DRUG: Colchicine

Sponsor

Scripps Translational Science Institute